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Abstract  
Background and purpose: The MRI only workflow aims to base the treatment planning solely on 
magnetic resonance imaging (MRI), hence excluding the traditional computed tomography (CT) scan. 
To do that synthetic computed tomography (sCT) data is generated, replacing the conventional CT data. 
The aim of this study was to investigate the possibility of using cone beam computed tomography 
(CBCT) images to verify the sCT data. This was done via investigation of the properties of the kV CBCT 
systems in the clinic and comparing dose distributions carried out on both the sCT and the CBCT data.  
Materials and methods: Several phantom measurements were made on the kV CBCT systems on the six 
Varian TrueBeamTM linac used in the clinic. The properties investigated were the variation in Hounsfield 
Units (HUs) over time for one kV CBCT system as well as variation between the six kV CBCT systems. 
The HUs of one kV CBCT system was also compared to HUs from a Siemens CT system. Using 28 
CBCT data sets from seven patients, a HU to relative electron density (RED) table was created. 
Treatment plans (RapidArc) were calculated on sCT, CT and CBCT images using the standard HU-
RED table based on CT HU. For the CBCT data, additional calculation was done using the HU-RED 
table based on CBCT HU. The difference between the dose distributions was evaluated comparing 
clinical dose volume histograms (DVH) and mean absorbed doses.  
Results: The phantom measurements showed that the kV CBCT system was stable in HU over time. All 
six kV CBCT systems generated comparable HU values. The variation of HUs between CT and CBCT 
images was minor. The CBCT images, however, exhibited larger variation across the field of view 
(FOV) compared to CT images. Dose calculation based on CBCT data showed a mean dose difference 
to PTV of 0.0% (HU-RED CT) and -0.8% (HU-RED CBCT) compared to dose calculations based on 
sCT data.  
Conclusion: The HUs for one kV CBCT system were found to stable over time. The variation between 
the six kV CBCT systems were found to be minor. Results obtained for one system can therefore be 
transferred onto all the systems. The minor difference in HUs between CT and CBCT images indicates 
that a correction of HUs is not necessary to obtain sufficiently accurate absorbed dose calculations on 
CBCT images. The compared dose distributions based on CBCT and sCT data showed good agreement 
in terms of dose accuracy, regardless of which HU-RED table used. This indicates that CBCT data can 
be used to verify sCT data.  
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Popular scientific summary in Swedish  
En tredjedel av de män som diagnostiseras med cancer i Sverige idag diagnostiseras med prostatacancer. 
Prostatacancer är den vanligaste förkommande cancerformen i Sverige. Det finns flera 
behandlingsmetoder för prostatacancer, en utav dem är extern strålbehandling. Vid behandling med 
denna metod bestrålas prostatan med en strålkälla som befinner sig utanför kroppen. En liten stråldos 
ges vid flera olika tillfällen och det är viktigt att man ligger likadant vid varje tillfälle.  
Innan man kan starta sin strålbehandling måste vissa förberedelser utföras. Ett vanligt förberedande steg 
för prostatacancerpatienter är att genomgå en magnetresonans (MR)-undersökning. Detta är en 
undersökning som med hjälp av magnetism skapar tredimensionella bilder av kroppens inre. MR är en 
bildmetod som ger anatomisk information och har fördelen att mycket gott kunna avbilda mjukvävnad 
som till exempel prostatan. Bildmetoden har även goda förutsättningar att visa tumörutbredning. Detta 
ger att man noggrant kan bestämma cancerns utbredning och läge.   
Patienterna genomgår även en datortomografi, kallad CT. Detta är en undersökning som med hjälp av 
röntgenstrålar skapar tredimensionella bilder av kroppens inre. Förutom att ge anatomisk information 
ger bilderna även information om hur röntgenstrålningen dämpas i kroppen. Med kombination av MR- 
och CT-bilder bestämmer läkare vilket område som ska bestrålas och vilka områden som ska undvikas 
för att skona känsliga organ. Sedan görs en behandlingsplan där man detaljerat planerar så att rätt mängd 
stråldos hamnar på rätt plats.  
För att möjliggöra ett enklare arbetsflöde har forskare visat ett intresse för att enbart använda sig av MR-
bilder i förberedelserna och utesluta CT-bilder. Detta gör att de osäkerheter som tillkommer då man 
kombinerar de båda bildtyperna försvinner. Dock har man problemet att MR-bilder inte ensam besitter 
den information som krävs för att skapa behandlingsplaner. För att lösa detta har man utvecklat en metod 
som omvandlar MR-bilderna till bilder som ser ut och kan användas inom dosplanering på samma sätt 
som CT-bilderna. Dessa bilder kallas syntetiska CT-bilder.  
De olika stegen i förberedelserna inför strålbehandling kontrolleras av sjuksköterskor, läkare och fysiker 
för att säkerhetsställa att allt är korrekt. Vid införande av syntetiska CT-bilder behövs ett 
tillvägagångssätt för att kontrollera att de skapade bilderna är korrekta. Idag görs detta genom att jämföra 
de syntetiska CT-bilderna mot de fortfarande existerande CT-bilderna. Men om CT-bilderna ska tas bort 
krävs ett annat tillvägagångssätt. Detta arbete föreslår en metod för hur detta skulle kunna gå till samt 
utvärderar resultatet och jämför mot den redan existerande metoden. Den nya metoden utgörs av att de 
syntetiska CT-bilderna jämförs mot en bild som tas på patienten inne i behandlingsrummet med 
behandlingsapparaten. Resultatet av studien visar att den nya föreslagna metoden på ett lovande vis kan 
användas för kontroll av syntetiska CT-bilder. Med vidare undersökning kan den nya metoden införas i 
den kliniska verksamheten.  
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1.  Introduction  
1.1. Background  
In 2014 cancer was the second most common cause of death in Sweden, and about 64 000 cases 
were registered [1]. A common approach to treat cancer is to use radiation therapy that uses radiation 
with high energy photons. Radiation therapy accounts for 30 percent of all cancer cures and about 
half of all cancer patients receive radiation therapy at some point during their treatment [2]. External 
beam radiotherapy (EBRT) is a non-invasive type of radiation treatment, with the aim of delivering 
high absorbed dose to the tumour while keeping the dose as low as possible to the surrounding 
normal tissue. In order to achieve that goal, a high accuracy is required in the treatment process.  
There are different steps in the treatment process, which together can be described as a radiotherapy 
workflow. This starts with a treatment prescription and ends with a completed treatment. One step 
in the workflow is an examination with an imaging modality called computed tomography (CT).  
The CT image provides Hounsfield Units (HUs) that the treatment planning system (TPS) requires. 
To be able to perform absorbed dose calculations the TPS converts HU to corresponding relative 
electron density (RED). The RED is the electron density in a material relative to the electron density 
in water. The CT images are also used when delineating the planning target volume (PTV) and the 
organs at risk (OAR), which the TPS uses to develop an advanced treatment plan.  
For some diagnoses, such as prostate cancer, magnetic resonance imaging (MRI) is preferred as a 
complementary imaging modality. The MRI images enables a more accurate definition of the 
prostate target volume and delineation of the OARs due to the superior soft tissue contrast of MRI 
images compared to CT images [3]. When both CT and MRI images are used, a co-registration of 
the two image data sets are used to create a treatment plan. The MRI enables accurate target 
delineation and the CT provides the HUs needed for absorbed dose calculation. Although this is a 
common procedure, the co-registration process is associated with systematic registration 
uncertainties. It has been estimated that the registration error for prostate plans is approximately 2 
mm for an automated registration process. The registration error is based on average offset in the 
three orthogonal dimensions [4]. The reason for the uncertainty is variation in patient set up and the 
elapsed time between the two scanning modalities. The anatomical relationship for some organs 
may have changed while waiting for the second imaging, such as filling of the rectum and/or bladder 
[4]. Therefore, interest has been directed towards a workflow using MRI as the only imaging 
modality – often denoted as an MRI only workflow. 
MRI only radiotherapy excludes the co-registration between CT and MRI images and hence the 
systematic registration errors will be reduced [4]. It will also simplify the workflow, and reduces 
the workload and therefore become more cost effective [5]. Another advantage of using MRI only 
is a tighter delineation of the mean prostate volume, a result of the improved image contrast. The 
delineation in the MRI has been shown to be smaller (32-40%) than delineated in the CT. This leads 
to a more precise description of the prostate target volume, and the possibility of sparing more 
surrounding tissue and OARs from irradiation [3][6][7]. Although, one should consider that the 
outcome of treatment when using a tighter delineation of the prostate volume has not been 
investigated. The Swedish consortium Gentle Radiotherapy (www.gentleradiotherapy.com) has 
since 2013 been working towards a radiotherapy workflow incorporating all advantages of using 
MRI in radiotherapy. The project is currently in the process of implementing the MRI only workflow 
for a number of different diagnoses. 
An obstacle using an MRI only workflow is the absence of HUs in the MRI which are required for 
absorbed dose calculation. A solution to solve this is to introduce a conversion step to replace the 
co-registration step. The conversion step consists of creating a synthetic CT (sCT) data set from the 
MRI image. The sCT images is a substitute for the CT images and is generated via various methods 
[8]–[16]. One way to verify if the HUs in the sCT images are generated correctly is to compare 
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absorbed dose calculations done on the sCT data and the CT data. But in an MRI only workflow the 
CT is not a part of the imaging procedure, and hence another method for sCT data verification must 
be considered. An previous suggested idea to verify the sCT data is to use a cone beam CT (CBCT) 
data set [17]. The CBCT is a kilovoltage based imaging modality used to confirm the patient set up 
in the treatment room before treatment.  
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1.2. Aim  
The aim of this study was to evaluate a method to verify the sCT image when there is no CT image 
available, using the CBCT image instead. This includes two parts; investigating properties of the 
kV CBCT systems with phantom measurements, and developing a HU to RED table based on CBCT 
images. To evaluate the table, a treatment plan is created and applied on both the sCT and CBCT 
images. Absorbed dose calculations are carried out on each data set and the two dose distributions 
are compared.  
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2. Theory  
2.1. Imaging modalities  
2.1.1. Computed Tomography  
The CT was first introduced to the world and clinic in 1971 and was used for diagnostics. The 
image consists of measured x-ray transmission profiles that have passed thorough the patient in 
many angles. To accomplish a profile a detector arc is required. This generally consists of 800-
900 elements lined up in a row. The x-ray tube and the detector package is mechanically 
interconnected and rotates around the patient. Using a number of detector rows aligned provides 
a more rapid acquisition. This is called a multidetector row CT (MDCT) and this method 
shortens the scan time, permits larger scan areas and enables thinner slices [18].  
The imaging system setup for a CT is an x-ray tube, collimators, beam shaping filters and 
detector. These components can be found in the gantry and are rotated around a sliding table, 
creating a helical CT [18]. 
The beam from the x-ray tube is collimated into a fan shape. Filters are positioned directly after 
the output from the x-ray tube. These filters are called the flattening filter and bow-tie filter. 
Flattening filters remove low energy x-rays from the beam, sparing the patient from unnecessary 
extra dose. Bow-tie filers shape the energy distribution across the beam according to the shape 
of the patient. After exiting the patient, the beam is collimated by a grid which rejects the 
scattered photons [18]. 
The CT detectors are scintillators and photodiodes. The detector row is divided into detector 
elements separated by septa to prevent light from one element being detected in a neighbouring 
element. In a MDCT the detector arc consists of up to 320 detector rows making it possible to 
cover up to 16 cm longitudinally in a single rotation [18]. 
The measured transmission profiles are used to reconstruct the CT image. This is done via an 
analytic method or an iterative method resulting in a matrix of pixels. Each pixel has a value 
that corresponds to the linear attenuation coefficient of the tissue present along the relevant 
transmission path. The linear attenuation coefficient depends on the density and composition of 
the material and the photon energy. The matrix of linear attenuation coefficients is then 
transformed into a corresponding matrix of Hounsfield Units (HU). HU is described in more 
detail in 2.2. This is a scale of radiodensity that is expressed relative to the linear attenuation 
coefficient of water at room temperature [18]. 
 
2.1.2. Cone Beam Computed Tomography  
A CBCT is a CT scanner developed to cover large scanning areas in one rotation.  This makes 
it suitable for different clinical applications such as pre-treatment verification of patient 
positioning and target volume localization in radiotherapy. The CBCT has different design 
features, image quality characteristics and application domains compared to the MDCT scanner. 
The largest difference is that the CBCT uses a two-dimensional (2D) digital flat-panel detector 
(FPD) to yield a three-dimensional (3D) volumetric image in just one rotation. One can consider 
that the 2D detector array has replaced the rows of detector elements [19].  
In a CBCT the x-ray tube generates a broad, cone-shaped beam of radiation. To do that the x-
ray tube is designed with a larger anode angle compared to the MDCT x-ray tube. This results 
in a field of view (FOV), in one rotation, to be as large as 25 cm in the rotating direction and 20 
cm in the z-direction. The down side to using a large FOV is that the entire volume generates 
scatter radiation contributing to a significantly poorer image quality [19].  
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The filtration in a CBCT involves a bow-tie filter. It contributes to lower absorbed dose to the 
patient and improves tomographic imaging quality since it improves the uniformity, HUs 
accuracy and contrast-to-noise ratio. The disadvantage to using a bow-tie filter is that the 
detector efficiency decreases due to beam hardening [19]. This phenomenon occurs since the x-
ray source emits a broad spectrum of energies where photons of higher energies typically 
attenuates less. This leads that the mean energy of the emitted x-rays increases when passing an 
object, causing an underestimation of the objects thickness.  
There are two different acquisition modes that can be used when imaging with a CBCT. These 
provide two different FOVs, full-fan mode and half-fan mode seen in Figure 1. When the image 
target is less than 24 cm in width the full-fan mode is appropriate. For larger objects, such as 
the pelvis, the half-fan mode is preferable [20]. Using the latter mode, the object is scanned 
asymmetrically using two 180° rotations at which the FPD is shifted laterally for the second 
rotation and a half bow-tie filter is used. This enables coverage of larger areas [19].  
 
Figure 1. The acquisition modes for CBCT. To the left the full-fan mode is illustrated and to the right the half-
fan mode. Image inspired from [20] 
Using a FPD makes it possible to use a wide cone beam and thus a large longitudinal coverage 
and it enables high spatial resolution. The high spatial resolution makes the CBCT suitable for 
imaging high-contrast structures. The FPDs dynamic range of meeting the linearity condition 
between input signal and output signal is lower compared to the detector system in MDCT 
scanners, resulting in lower soft tissue contrast and longer scan time. The FPD can consist of a 
matrix of detector elements from 5 x 5 cm2 to 40 x 40 cm2. This makes it possible to image an 
entire organ such as brain, heart or liver in just one axial scan [19]. 
In radiation therapy, the CBCT is mainly used for patient positioning registering the CBCT 
image with the planning CT image. The target can be precisely aligned with the therapeutic x-
ray beam from the linear accelerator. Most treatment centres use a kV CBCT where the x-ray 
tube and FPD is mounted on the gantry of the linear accelerator in an orientation that is 
orthogonal to the therapeutic beam. When imaging, the gantry rotates 360° creating a 
tomographic image. The CBCT image is sometimes also used during the radiotherapy treatment 
course for detection of day to day anatomical changes in soft tissue such as intestinal movement 
[19]. 
 
2.1.3. Synthetic Computed Tomography  
In comparison to CT images, the MRI images does not provide physical properties of the tissue 
such as HUs. The HUs are converted into electron densities required for absorbed dose 
calculations. Over the past years, several different methods for converting MRI data into sCT 
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data have been suggested [8]–[16]. Most of them are in-house developed, but commercial 
solutions have also been presented [15][16]. 
 
There are different approaches for in-house developed sCT softwares. One method is to apply 
bulk electron densities to the MRI. The original pixel values are overwritten with a single 
electron density value. This could be applied on the entire body or on segmented contoured 
structure volumes [10][11]. Another method is the atlas-based method where MRI atlas and 
conjugate electron density atlas is used. The MRI atlas is based on manually delineated MRI 
images and is used to automatically segment organs. The conjugate electron density atlas is 
based on co-registered MRI and CT images. It is used to map electron densities to the segmented 
MRI image, creating a sCT image [8].    
 
Skåne University Hospital and Norrland University Hospital has together with Spectronic 
Medical AB developed a method that automatically generates sCT directly from the MRI, using 
the Statistical Decomposition Algorithm (SDA) [16]. The method has since become a 
commercial solution, MriPlannerTM (Spectronic Medical AB, Helsingborg, Sweden) and is 
currently in use for external radiotherapy of prostate cancer within the study MR-only Prostate 
RadiOTherapy Excluding CT (MR-PROTECT). The SDA is a population driven algorithm that 
automatically generates sCT images from standard T2 weighted MRI images. Using a template 
database containing MRI and CT image pairs and automatic tissue segmentation, the algorithm 
estimates the most probable CT images representation for the incoming MRI images [16].  
 
To decompose and delineate the tissue classes in the incoming MRI images, the SDA applies 
an automated segmentation algorithm. After that, each set in the template database is deformed 
so that their segmented structures align with the ones on the incoming MRI images. The result 
is then applied to the respective template CT data sets. From this, the most probable CT images 
representation of each tissue type is found in the template database. The found tissue types are 
then fused together into one final sCT data set [16].  
 
Since the sCT images is derived from the MRI images, the sCT images has the same resolution, 
frame of reference, body outline and FOV as the MRI images. The main requirement for the 
incoming MRI images is that the acquisition of the contrast broadly resembles the template MRI 
images since the SDA mainly operates by identifying and structuring visual features in the 
image. The incoming MRI image also has additional requirements to allow dose calculation on 
the generated sCT image. The FOV must encompass the entire volume of the patient and since 
spatial resolution in the sCT images is equal to the resolution in the incoming MRI images it 
must be sufficient [16]. The MRI acquisition sequence parameters used in this thesis were the 
same as presented in the MR-Only Prostate External Radiotherapy (MR-OPERA) study [21].  
 
Creating sCT images using SDA and comparing the average mean absorbed dose difference in 
PTV between sCT images and registered CT images, the difference was 0.0% ± 0.2% (1 SD). 
Compared to the uncertainties with the uncertainties that may arise from varying patient 
positioning between imaging sessions, the dosimetric uncertainties coupled to the SDA are 
notably lower and clinically negligible [16].  
 
In the MR-OPERA study, the ability to verify dosimetric accuracy and robustness in the 
commercially available software MriPlannerTM was investigated. This software converts the 
MRI images to sCT images of the male pelvis using SDA. The dose differences between plans 
generated on CT images and sCT images was small. The result was statistically equivalent at a 
95% confidence level within ±0.5%. Catastrophic errors were not found in the sCT image 
conversion in the MR-OPERA study. Although, an outlier detection is needed when introducing 
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an MRI only workflow. The outlier detection should detect errors in the sCT image and prevent 
the treatment planning process to continue. The authors suggested that a sanity check of the HU 
distribution in the CT images and sCT images could be done and that it would be sufficient [21] 
However, since the aim for an MRI only workflow is to exclude the CT images entirely another 
method for outlier detection must be developed. One suggestion could be to use the CBCT 
images to verify the sCT images. 
 
2.2. Hounsfield Units  
HU are a transformation of the linear attenuation coefficient of the interacting material (𝜇𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙) 
and are expressed relative to the linear attenuation coefficient of water at room temperature 
(𝜇𝑤𝑎𝑡𝑒𝑟). The corresponding HU of a voxel is given by equation 1. 
HUmaterial=
μ
material 
- μ
water
μ
water
- μ
air
∙1000 
1 
meaning that a change of 1 HU corresponds to a change of 0.1% of the linear attenuation coefficient 
of water. Water has a HU of zero since μ
material
 = μ
water
 and air a HU of -1000 since μ
water 
= 0 [18]. 
Typical HUs for different tissues, measured in a CT image, can be studied in Table 1.   
The output from the x-ray tube consists of a range of photon energies resulting in a non-constant μ. 
The photon energy selected will therefore generate different HU in the same object. Due to 
differences in average photon energy in the x-ray spectra, the materials exhibit a non-linear 
relationship to their linear attenuation coefficient relative to water. The μ for water increases at lower 
energies, resulting in beam hardening. The reconstructing algorithm for CT applies a correction for 
beam hardening in water forcing the μ to be constant for water. Other materials will have a μ 
depending on density and structure of the material and the beam hardening [22].    
Calibrations of the HU and beam hardening corrections is done for the MDCT. This is typically 
absent for the CBCT and the values for HUs are more variable compared to those from the MDCT. 
The uniformity of the HU in an entire cross-section of a homogenous object is not uniform. At the 
edges the HUs decrease [19]. When scanning bigger objects such as the pelvis and doing larger 
volumetric reconstructions the effect of scatter becomes substantial. X-ray scatter results in artifacts 
in the image such as cupping artifacts and/or streak artifacts and quantitative inaccuracy in 
reconstructed HU [23]. 
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Table 1. Typical HU values for different types of tissues measured in a CT image. The range is from about -1000 HU 
to 1000 HU. The higher density a material has, the higher the HU becomes. The values are taken from Dance et al. 
[18]   
Tissue HU 
Compact bone +1000 (+300 to + 2500) 
Liver +60 (+50 to +70) 
Muscle +25 (+10 to +40)  
Water 0  
Fat -90 (-100 to -80) 
Lung -750 (-950 to -600) 
Air -1000 
 
 
2.3. Dose calculation on CBCT  
Richter et al. [24] investigated the feasibility and accuracy for dose calculation in CBCT images 
acquired from the CBCT system Synergy XVI Elekta. This was done to establish if CBCT images 
could be used for treatment planning. Phantom measurements were performed to investigate the 
relationship between HU and corresponding RED for different materials in both planning CT and 
CBCT images. From these measurements, density calibration tables (HU-RED table) were 
specified. These were the standard HU-RED CT table and the phantom based HU-RED CBCT table. 
Dose calculation on the phantom CBCT image was performed with the standard HU-RED CT table 
and the phantom based HU-RED CBCT table. The dose distributions were compared with the dose 
distribution carried out on planning CT images. The comparison showed that calibration using 
phantom based HU-RED CBCT table gave least deviation between the dose distributions calculated 
on CT and CBCT images. Dose calculations on patient CBCT images were performed using either 
the standard HU-RED CT table, the phantom based HU-RED CBCT table, the patient group based 
HU-RED CBCT table or the patient individual HU-RED CBCT table. A patient group based HU-
RED CBCT table was developed using many patients CBCT images, calculating mean HU values 
for tissues. A patient individual HU-RED CBCT table was determined for each patient, resulting in 
every patient having an individual table. Using the standard HU-RED CT table and the phantom 
based HU-RED CBCT table led to inaccurate dose distribution on CBCT images in pelvis patients. 
The patient group and patient individual based HU-RED CBCT tables generated accurate dose 
distribution in the pelvis region. The final result indicated that accurate dose distribution could be 
feasible in CBCT images if correction of the HUs were done.  
de Smet et al. [25] studied the accuracy of dose calculation on kV CBCT images of lung cancer 
patients. First, they investigated the variation in CBCT HU for six Varian On-Board Imager 
TrueBeam system using a phantom. The result showed good correspondence between the systems. 
The maximum difference was 30 HU for Teflon. Further, they looked up the difference in HU 
between CBCT and CT images for lung patients. They concluded that HUs for lung tissue varied 
too much to rely on manually overriding densities and then perform dose calculations. The Varian 
On-Board Imager TrueBeam had small difference between CT and CBCT HU numbers for high 
density tissues in the thorax region, for example muscle. Therefore, a patient group HU-RED CBCT 
table was produced correcting only for the average differences in HU for lung tissue of six lung 
patients. Dose calculation using the standard HU-RED CT table was performed on CBCT images. 
The dose distribution was then recalculated using the patient group or patient specific HU-RED 
CBCT table. The patient group and the patient specific HU-RED CBCT table for Varian On-Board 
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Imager TrueBeam gave approximately the same result when calculating dose distributions. The 
result showed 1%-2% difference in dose distribution compared to the distribution calculated on CT 
images. The standard HU-RED CT table gave results with differences of 2%-3%. The overall result 
indicated that accurate dose distribution could be obtained on CBCT images without HU correction 
for the Varian On-Board Imager TrueBeam system.    
Dunlop et al. [26] performed an investigation comparing different CT number calibration techniques 
for CBCT based dose calculation. The CBCT system used in this study was XVI (v.4.5) Elekta. One 
technique was to use a CBCT reconstruction to adjust the HUs. The reconstruction was corrected 
for scatter using an in-house software. Then a patient-independent table was applied to the 
reconstructed images to convert HU in to RED. Another technique evaluated was density overrides. 
The “water only”, “water-and-bone” and “water-and-lung” methods were investigated. For “water 
only” all tissue was assigned as water. For “water-and-bone” was the tissue assigned as either water 
or bone and for “water-and-lung” was the tissue assigned either as water or lung. Also investigated 
was the CBCT density-assignment tools available in the TPS where six different densities were 
assigned to the CBCT image. The study showed that HU adjustment using CBCT density-
assignment tools provided a similar CBCT dose calculation as the calculation done on CT images. 
It was the best method for pelvis patients without excess adipose tissue and was the method they 
recommend for accurate dose calculations.  
Edmund et al. [17] examined the possibility of using CBCT guided treatment delivery and planning 
verification for MRI only radiotherapy of the brain. The CBCT images in the study was acquired 
from Varian On-Board Imager (v.1.6). In MRI only radiotherapy one step was to estimate if the 
CBCT data could provide reliable error estimation of the sCT data. To do that they needed to 
transform the CBCT HU to RED using conversion curves. These were either phantom based or 
population based. To quantify the error estimation, they statistically evaluated the median value of 
the binned absolute errors. When transferring the data into RED the median absolute error (MeAE) 
value for CT data and CBCT data became closer. The conclusion was the correctness of sCT data 
could be verified from CBCT data using a population based conversion curve. 
The conclusion for all studies was that treatment planning on CBCT images was feasible. Some of 
the studies estimated that a HU-RED table based on CBCT images, correcting the HUs, was required 
to obtain an accurate dose distributions.   
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3. Materials and methods  
3.1. Phantom measurements  
3.1.1. Phantom material  
The phantom used was the CIRS Model 062M Electron Density Phantom with associated 
electron density plugs. The phantom consists of two nested disks made of Plastic Water®-LR. 
The inner disk represents a brain configuration. Combining the outer and inner disk represents 
an abdomen configuration. In this study, the abdomen configuration was used. Ten different 
tissue equivalent electron density plugs can be positioned in seventeen different locations within 
the phantom. The tissue types and corresponding RED can be seen in Table 2. Two additional 
50 mm thick bolus slabs made of Plastic Water®-LR were used as scattering material as 
recommended in the user guide [27] by the manufacturer (Computerized Imaging Reference 
Systems, INC., Norfolk, Virginia, USA).  
The images analysed and all the measurements in this study were acquired from the kV CBCT 
system used for image-guided radiotherapy, Varian On-Board ImagerTM TrueBeamTM. 
Evaluations of the phantom measurements were carried out on the CBCT images in the 
registration module Eclipse Image Registration (Varian Medical Systems v. 13.6, Palo Alto, 
CA). 
Table 2. Tissue and corresponding RED for the different phantom electron density plugs.   
Tissue RED 
Lung Inhale 0.190  
Lung Exhale 0.489 
Adipose 0.949 
Brest 50% Gland 50% Adipose 0.976 
Water 0.998 
Muscle 1.043 
Liver 1.052 
Solid Trabecular Bone 200 mg/cc HA 1.117 
Solid Dense Bone 800 mg/cc HA 1.456 
Solid Dense Bone 1250 mg/cc HA 1.695 
 
 
3.1.2. Constancy of HU over time  
To confirm that the measurements done on CBCT images can be used in the future, an 
investigation of constancy of HU over time was made. A weekly CBCT measurement was 
carried out on one out of six available Varian On-Board ImagerTM TrueBeamTM in our clinic 
where MRI only treatments currently are scheduled. The CIRS phantom was the object imaged. 
This had the recommended arrangement seen in Figure 2, for optimal positioning of the electron 
density plugs according to the manufacturer (Computerized Imaging Reference Systems, INC., 
Norfolk, Virginia, USA). Figure 2 also displays the setup of the phantom.   
The image was obtained in CBCT Pelvis Mode, that is in half-fan mode and a 360° rotation of 
the gantry. The parameters were 125 kV, 1080 mAs and the reconstruction was set to 3 mm 
slice thickness. The electron density plugs were evaluated in the CBCT images using the profile 
tool in Eclipse Image Registration. This can be seen in Figure 3.  
The values noted for each individual profile were the minimum, maximum, mean and the 
standard deviation (SD). The aggregated mean value of the individual mean HU values was 
calculated as well as the associated SD.  
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Figure 2. To the left, the recommended arrangement of the tissue electron density plugs is seen. In the middle and 
to the right, the setup of the phantom.   
 
 
Figure 3. The profile used when extracting HU for each material. The profile was placed in the centre of each 
material. In this image, the profile is drawn in Bone 800 mg/cc HA.   
 
3.1.3. Consistency of HU between kV CBCT systems  
To investigate whether the HUs are constant between the kV CBCT systems in the clinic, an 
identical measurement was carried out on each of the six systems. The same setup and 
acquisition mode as the constancy over time measurements was used for each machine.  
The images were evaluated in Eclipse Image Registration using a profile acquired from each 
material, as can be seen in Figure 3Figure 3. The mean and SD values were noted. For all the 
measurements, the aggregated mean value of the individual mean HU values was calculated 
along with the corresponding SD.  
 
3.1.4. Constancy of HU in FOV 
It was of interest to know if the signal in different parts of the FOV was constant for dissimilar 
materials. The materials used to evaluate the constancy were the electron density plugs 
equivalent to lung inhale, water and solid dense bone 1250 mg/cc. These are materials with low, 
medium and high RED. The same setup and acquisition mode was used as for the constancy 
over time measurements. Five measurements were carried out for each material with the 
respective plug positioned in different cavities for each measurement. Position were the centre, 
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left, right, upper and lower cavity of the phantom. The surrounding cavities were filled with 
water equivalent material.  
An image was obtained for each position of the materials and the mean HU value was evaluated 
in Eclipse Image Registration using a region of interest (ROI) within an area of 1 x 1 cm applied 
as centred as possible in the plug. An example is shown in Figure 4 with solid dense bone in the 
centre cavity.   
The whole procedure was repeated three times separated over time on the same accelerator 
giving three measurement points for every position and material. For these measurements, the 
aggregated mean value of the individual mean HU values was calculated as well as the related 
SD. The study also evaluated HUs in the FOV for one Siemens CT system. This was based on 
one measurement.  
 
Figure 4. The ROI used to extract HU in various positions for lung inhale, water and solid dense bone 1250 mg/cc 
HA. The ROI was applied in the centre of each position. In this image, the ROI is applied on solid dense bone 
1250 mg/cc HA placed in the centre position.  
 
3.2. Patient specific measurements  
3.2.1. Patient material  
In this study patients were selected retrospectively from the previously conducted MR-OPERA 
study, approved by the Ethical Review Board. The patients in the study had undergone 
radiotherapy either for prostate cancer or for prostate and glandular cancer. For the purpose of 
the present study, patients treated for both prostate and glandular cancer were selected. These 
patients had CBCT images acquired as a part of their daily imaging procedure to assure correct 
patient positioning prior treatment. The CBCT images can be acquired with different parameter 
settings, depending on the used protocol. For consistency, only CBCT data acquired with the 
same parameter settings were used and in total data from seven patients were included in the 
study.  
Four CBCT images from each patient were used for the image analysis, giving a total number 
of 28 CBCT images. All of the CBCT images were acquired in CBCT Pelvis Mode with the 
predetermined acquisition parameters seen in Table 3. Reconstruction thickness was set to 3 
mm, which was the same slice thickness as in the acquired CT images for the patients.   
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Table 3. The predetermined acquisition parameters for CBCT Pelvis Mode.  
Acquisition Parameters 
Fan Type Half 
Trajectory Full 
kV 125 
mAs 1080 
CTDIw 1.60 Gy 
 
 
3.2.2. HU to RED table  
Performing dose calculation requires RED. To obtain this a HU to RED table is used in the TPS 
transforming HU in CT images to corresponding RED. The table used in the clinic can be seen 
in Table 6.  
It is established that the HUs in CBCT images can differ from the ones in CT images [19][23]. 
This could mean that the standard HU to RED table (HU-RED CT) used when dose calculating 
may assign incorrect RED to the CBCT image leading to incorrect dose calculation. To correct 
this, a different HU to RED table grounded on CBCT images HUs can be used (HU-RED 
CBCT).  
The generation of the HU-RED CBCT table was done in an in-house developed MATLAB 
(MATLAB R2016a, The MathWorks, Inc., Natick, Massachusetts, United States) program. The 
generation of the table was population specific which is the preferred method of use according 
to previous studies [17][24][25]. From each patient, four CBCT data sets were selected and the 
voxel values were summed up creating a mean value histogram for all patients. For air, fat and 
muscle the mean HU was extracted from the histogram using peak analysis that generates the 
locations of local maxima. These values were assigned to the expected corresponding RED 
described in Table 2. To cover the entire clinically relevant HU span, a value for solid dense 
bone was desirable. Unfortunately, this could not be obtained using the same method as for air, 
fat and muscle. To obtain the value, the measurements carried out on the phantom to evaluate 
the constancy of HU in the FOV was used. The mean HU of solid dense bone was assigned the 
corresponding RED given in Table 2. A fifth HU value representing materials such as metal had 
been assigned in the standard HU-RED CT table. This value was matched and corresponding 
RED was extrapolated assuming a linear relationship. 
 
3.2.3. Treatment Planning 
Four out of the seven patients were suitable for treatment planning since the three remaining 
patients had an insufficient coverage of the target area on the CBCT images, making absorbed 
dose calculations unfeasible.  
For each patient, a sCT data set was created via the MriPlannerTM software (Spectronic Medical 
AB, Sweden). The sCT images had the same resolution, frame of reference, body outline and 
FOV as the MRI images. The clinical target volume (CTV), consisted the prostate, and OARs 
were automatically segmented on the MRI images in the MriPlannerTM software and transferred 
onto the sCT images. Since the MRI images is the primary image modality in an MRI only 
workflow, the CT and CBCT images were rigidly registered based on bone anatomy to the sCT 
and re-sliced to the same slice thickness (2.5 mm) as the MRI images. The body outlines were 
cropped to be the same as the MRI images. If the body outlines in the CT and CBCT images 
transcended the body outline in the MRI images, the transcended part was eliminated in the CT 
and CBCT images. If the situation was reversed the body outlines in the CT and CBCT images 
was extended with water equivalent HUs resulting in the same body outline as in the MRI 
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images. The sCT, CT and CBCT images were returned to the Eclipse treatment planning system 
(Varian Medical Systems, Palo Alto, CA) in the same frame of reference as the MRI images. 
Re-slicing, body cropping and setting the frame of reference was made as a pre-processing by 
Spectronic Medical before the images was returned to the TPS.  
In this study RapidArc was the technique chosen to generate an initial treatment plan on the sCT 
images. The PTV was created by 7 mm expansion of the CTV in all directions. The energy used 
was 10 MV and the prescribed dose was 78 Gy with 2 Gy per fraction, concluding in a total of 
39 fractions. In Eclipse TPS, the Dose Volume Optimizer (v. 10.0.28) was used for plan 
optimisation and final dose calculation was performed with the AAA (Anisotropic Analytical 
Algorithm v. 13.6.23). The sCT plan was normalised to 100% to the mean PTV target dose. All 
treatment plans were set to fulfil the dose volume constraints for the conventional arm in the 
Swedish multicentre Phase III study of HYPO-fractionated Radiotherapy of intermediate risk 
localised Prostate Cancer (HYPO-RT-PC) [28]. The constraints can be seen in Table 4.   
To enable evaluation in between absorbed dose calculations carried out on sCT, CT and CBCT 
images, the structure set from the sCT images was copied and transferred to the CT and CBCT 
images. The treatment plan copied to the CT and CBCT images was creating plans identical to 
the initial sCT plan. For the CBCT images, the treatment plan was recalculated twice, first with 
the original HU-RED CT table applied on the CBCT images and then with the developed HU-
RED CBCT table, both seen in Table 6. This concluded in four different plans for each patient 
denoted sCT, CT, CBCTHU-RED CT, CBCTHU-RED CBCT.  
Table 4. The dose volume constrains for the conventional arm in the HYPO-RT-PC study. The priority of fulfilling 
the dose volume constrain can be seen as well as what volume the dose volume constrain influence.  
Priority  Volume Dose Volume Constraints 
1 CTV Dmin ≥ 95% 
Dmin ≥ 74 Gy 
2 PTV V95% ≥ 95% 
V74Gy ≥ 95% 
3 Rectum V90% ≤ 15% 
V70Gy ≤ 15% 
4 PTV D99% ≥ 90% 
D99% ≥ 70 Gy 
5 Rectum V75% ≤ 35% 
V59Gy ≤ 35% 
6 Femoral heads Dmax ≤ 70% 
Dmax ≤ 55 Gy 
7 Rectum V65% ≤ 45% 
V51Gy ≤ 45% 
8 Body Dmax ≤ 105% 
 
 
3.2.4. Evaluation 
To evaluate the differences in the four dose distributions MICE (Medical Interactive Creative 
Environment, v. 0.4.0.0, available at www.gentleradiotherapy.se) was used. This is a program 
that, by using the total plan dose matrix and structure set, can produce dose volume histograms 
and extract data that is of interest. Data of interest were the dose volume constraints from the 
HYPO-RT-PC study and the mean absorbed dose to the PTV, CTV and OARs.  
The difference in absorbed dose between the plans was then compared as CT/sCT, CBCTHU-RED 
CT/sCT and CBCTHU-RED CBCT/sCT for each patient. The mean value and SD for all patients was 
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calculated. For one of the patients, the CBCT image did not cover the entire rectum and therefore 
the rectum related dose volume constraints and rectum mean absorbed dose were excluded.   
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4. Results 
4.1. Phantom measurements  
4.1.1. Constancy of HU over time 
Figure 5 displays the aggregated mean HU value calculated from the measurements 
investigating the constancy of HU over time. HUs and corresponding SD for each tissue 
equivalent electron density plug are illustrated.  
The SD for the materials, excluding solid dense bone, ranged from 5.86 - 17.5 HU. Solid dense 
bone inserts, both with 800 and 1250 mg/cc, had a slightly larger SD at 27.9 and 39.6 
respectively compared to the other tissue inserts. Relative standard deviation was 3.21% for 
solid dense bone 800 mg/cc and 2.82% for solid dense bone 1250 mg/cc. The corresponding 
values for lung exhale and muscle was 0.91% and 11.4% respectively.   
All the HU values were within reasonable expected values acknowledged in Table 1. The 
maximum difference measured was for lung exhale inner and outer. These values were 153 HU 
and 105 HU higher that the highest value in the span. 
 
 
Figure 5. The mean HU value for ten tissue equivalent electron density plugs. Values denoted with a pentagram 
represented the plugs located in the outer disk. Values denoted with a dot represented the plugs located in the inner 
disk.  
 
4.1.2. Consistency of HU between kV CBCT systems 
The aggregated mean value of the individual mean HU values measured on the six kV CBCT 
system available in the clinic is illustrated in Figure 6. HUs and corresponding SD for each 
material inserts are shown.  
The largest difference between the accelerators was found for solid dense bone 1250 mg/cc. 
This was 178 HU and was considered small. The SD for all the materials, except solid dense 
bone 1250 mg/cc, ranged from 10.2 - 49.7 HU from the mean values. The SD for solid dense 
bone 1250 mg/cc was slightly larger (68.6 HU). The location of the material in the inner or outer 
disk did not affect the HU. In general, all the HUs for every material overlapped within one SD. 
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The HU for all the materials had values that were reasonable compared to the one acknowledged 
in Table 1.  
 
 
Figure 6. The mean HU value for the different materials measured on six kV CBCT systems. Value denoted with a 
circle represented the electron density plugs located in the outer disk. Values denoted with a star represented the 
electron density plugs located in the inner disk.   
 
4.1.3. Constancy of HU in FOV 
The aggregated mean HU value and SD in the FOV were demonstrated in Table 5, for CBCT 
and CT images. The deviation in HU between CT and CBCT images was minor. The largest 
difference in aggregated mean HU was 59 HU and seen for the solid dense bone 1250 mg/cc 
HA insert. Lung inhale and water inserts had a difference in aggregated mean HU of 30 HU. 
The relative standard deviation in lung inhale, water and solid dense bone 1250 mg/cc was for 
CT image 0.03%, 2.77% and 1.04% and for CBCT image 2.85%, 82.4% and 8.56% 
respectively.  
HU could be shown to fluctuate more within the CBCT images then in the CT images. The SD 
for lung inhale and solid dense bone within the CBCT images were approximately nine times 
larger than for the CT image. For water the SD was four times larger than in the CT image. 
Table 5. Aggregated mean HU values and SD for the different materials based on one CT and three CBCT data 
sets. The materials evaluated was lung inhale, water and solid dense bone 1250 mg/cc HA.  
 HU Lung Inhale HU Water HU Solid dense bone 
Image Mean SD Mean SD Mean SD 
CT -779 2.45 -1.94 5.37 1237 12.9 
CBCT  -808 23.0 28.4 23.4 1296 111 
 
 
4.2. Patient specific measurements  
4.2.1. HU to RED table 
The patient used to develop the HU-RED CBCT table had median weight of 87 kg and was 76 
years old. In Table 6a, the standard HU-RED CT table were showed. In Table 6b, the generated 
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HU-RED CBCT table. The first three HU value points represented air, fat and muscle were 
based on 28 CBCT images. The fourth was the mean value of solid dense bone measured in 
phantom. The fifth HU value point was selected to match the HU-RED CT and the 
corresponding RED was extrapolated assuming a linear relationship.  
Table 6a and 6b. The two HU-RED tabled used for absorbed dose calculation. The standard HU-RED CT (a) and 
the generated HU-RED CBCT (b). 
HU-RED CT  HU-RED CBCT 
HU Value [HU] RED  HU Value [HU] RED 
-1000 0,000 -1000 0,000 
-100 0,900 -102,0 0,949 
100,0 1,100 26,00 1,043 
1000 1,532 1296 1,695 
6000 3,920 6000 4,110 
a)                                                     b) 
 
4.2.2. Treatment planning  
The four plans created for every patient fulfilled the dose volume constrains except two plans 
for one patient. This was the CT plan and CBCTHU-RED CT plan. For these plans, maximum global 
dose (Body Dmax) exceeded 105% of the prescribed dose by 0.5%, which was minor and 
therefore did not have any impact on the result.   
The mean difference in absorbed dose for specific DVH metrics comparing the dose 
distributions for CT, CBCTHU-RED CT and CBCTHU-RED CBCT to the sCT dose distribution can be 
seen in Figure 7. The baseline of zero represents no difference between the DVH metrics 
compared. A deviation from the baseline represents a difference. The complete data for each 
patient can be seen in Appendix 1. 
The result for the comparison between sCT and CT dose distribution shows a small deviation 
for all DVH metrics evaluated. The maximum deviation is 0.2% corresponding to the rectum 
V90% point. The SD ranges from 0.0% to 0.5%.  
The difference in DVH metrics for the CBCTHU-RED CT/sCT dose distribution comparison is 
smaller for the PTV and CTV DVH metrics and in general larger for the OARs DVH metrics 
compared to CT/sCT dose distribution. All the DVH metrics, excluding the body max point, 
have a deviation that was lower than 0.3%. The SD is in general the same as the CT/sCT dose 
distribution comparison for all DVH metrics. The SD ranges from 0.1% to 0.5%. 
The CBCTHU-RED CBCT/sCT dose distribution comparison shows a deviation that is larger for most 
of the DVH metrics compared to the other comparisons. The largest deviation noted can be seen 
for PTV and CTV DVH metrics, but the deviations are below 1%. In this comparison, the SD 
is between 0.0% and 0.4% 
The results conclude that all the comparisons have a high agreement with all the DVH metrics 
with a similar set of standard deviations. 
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Figure 7. Percentage mean absorbed dose difference for specified DVH metrics for the three comparisons, CT/sCT 
(blue), CBCTHU-RED CT /sCT (red) and CBCTHU-RED CBCT /sCT (yellow). 
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5. Discussion  
5.1. Phantom measurements  
If the verification of sCT images is founded on CBCT images, it is essential to know how the kV 
CBCT systems behaves. Various measurements have therefore been carried out investigating 
different aspects. These measurements were carried out on a phantom in order to maintain a 
repeatable process.  
The results from the phantom measurements showed that the HUs were constant over 9 weeks 
period for all materials. This indicated that the system was robust and did not drift, allowing accurate 
HU measurements over time. No significant difference in HU was observed between the six kV 
CBCT systems in the clinic. This showed that all the CBCT systems generated HUs that were 
comparable to each other within the same material. Results from one kV CBCT system could be 
applied on all the systems. This is similar to previous results reported for Varian On-Board Imager 
TrueBeam [25]. The CBCT images exhibited similar mean HU values as the CT images which was 
also in agreement with previous work [25]. This indicated that a correction of the HUs was not 
needed for CBCT images. The SD was higher within the FOV for CBCT HU values then for CT 
HU values. This suggests that the CIRS Model 062M Electron Density Phantom may not be optimal 
for CBCT measurements and that a dedicated phantom for CBCT measurements might be a more 
suitable choice. This because a dedicated phantom for CBCT is designed to provide a reliable tool 
for HU to RED calibration in volumetric imaging using additional scattering material.      
The result presented in Figure 5 showed the constancy of HU over time for inserts with different 
tissue equivalent densities for one kV CBCT system. Comparing the measured values with the ones 
denoted in Table 1 a maximum difference of 153 HU and 105 HU for lung exhale inner and outer 
could be seen. The air value in Table 1 does not give any information about how it has been 
estimated and may not be measured in the same stage as lung exhale. This could be an explanation 
why this tissue exhibits the larges deviation. The SD for all of the electron density plugs was small 
compared to the uncertainty in HU accuracy estimated by IAEA in the publication about accuracy 
requirements and uncertainties in radiotherapy [29]. For a kV CBCT image the HU accuracy was 
estimated to be between 20-100 HU. Since the largest deviation was 39.6 HU it could be concluded 
that the HUs is constant over time for all materials for a Varian On-Board Imager TrueBeam.  
Skåne University Hospital has six different Varian On-Board Imager TrueBeam. Figure 6Figure 6 
displayed the mean HU value and SD for all kV CBCT systems, for each tissue equivalent electron 
density plug. When a CBCT system was installed a HU acceptance test was carried out. A tolerance 
level of ±50 HUs from the expected HU value must be achieved for materials ranging from -1000 
HU to 120 HU. The SD from the mean HU value for all kV CBCT systems for materials within -
1000 HU to 120 HU, had a value that were lower than the tolerance level. The acceptance test did 
not contain a tolerance level for high density material, but looking at the material that exceeded 120 
HU, i.e. bone, two out of three points had a SD that was below 50 HU. Solid dense bone 1250 mg/cc 
had a SD that was 68.6 HU but since the HU accuracy for a kV CBCT image was estimated to be 
20-100 HU [29], a surplus of 18.6 HU is insignificant. The results presented indicate that all the 
CBCT systems generate HUs that are comparable to each other for the investigated materials.  
Studying the result in Table 5, it can be seen that the difference in mean HU between CBCT images 
and CT images is minor. The difference for lung inhale and water is approximately 30 HU. For 
solid dense bone, a difference of 59 HU is established. Compared to the expected HU accuracy for 
a kV CBCT system [29] the differences are negligible. This suggests that a correction of the HU 
may not be necessary. The SD was higher for the mean HU estimated in the CBCT images compared 
to the SD for the mean HU estimated in the CT image. The mean HU in the CBCT images had a 
SD that was four to nine times larger, depending on which material, compared to the SD for the 
mean HU in the CT image. It has been shown in previous work [30] and stated in the theory [23] 
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that a large scan object entails larger presence of scatter for the cone beam geometry. The increase 
in scatter contamination affected the reconstruction of the image resulting in an impact on the HUs. 
This might be one explanation of why there was higher SD within the FOV of the CBCT images.   
The measurements carried out in this thesis were done using a phantom, with a size representing an 
abdomen configuration. This size is classified as a larger object which leads to an increase in the 
scatter contamination for the CBCT images compared to the CT images. 
  
5.2. Patient specific measurements  
In external radiotherapy, it is essential to ensure that high accuracy is maintained. To be able to do 
that quality controls and quality assurance is carried out throughout the radiotherapy chain. When 
introducing treatment planning on sCT images it must be ensured that the images have been 
generated correctly and that they provide the same information as the CT images would have. In an 
MRI only workflow, creating treatment plans with the CBCT as the image material and then 
comparing the dose distribution with the sCT based treatment plan is a method we propose to ensure 
quality accuracy of the sCT image. 
Edmund et al. has in previous work presented a way to verify the sCT data using the CBCT data. 
By creating HU-RED curves and statistically analysing median value of the binned absolute errors, 
they concluded that verification of the sCT data could be done with CBCT data using a population 
based calibration curve [17]. From this study, interest arose in further work to calculate absorbed 
dose on CBCT images with a population based HU-RED table to verify the sCT images which was 
not investigated in Edmund et al.  
Previous work had also established that it was possible to accurately calculate absorbed dose on 
CBCT images. To obtain an accurate calculation, Richer et al. used a population based HU-RED 
table to correct HUs. This method gave a difference in absorbed dose, between calculations carried 
out on CT and CBCT images, that was less than 5% comparing DVH metrics [24]. de Smet et al. 
used the same approach to obtain accurate absorbed dose calculation. Their study showed that there 
was no need for HU correction when using kV CBCT systems from Varian TrueBeam. Using the 
standard HU-RED CT gave differences of 2% to 3 % for pelvis patients comparing DVH metrics. 
A population based HU-RED CBCT gave a better agreement. The difference was then 1% to 2% 
comparing DVH metrics [25]. In this study, a population based HU-RED CBCT table with one 
phantom based HU value was used for absorbed dose calculation. This was because previous work 
[17][24][25] has concluded that a population based table provides an accurate enough HU to RED 
conversion for CBCT images. It would have been preferable to use the same method to decide on 
the appropriate HU value for solid dense bone; however the lack of intensity of solid dense bone 
voxels prevented the HU value being extracted in this way. Thresholding is another method that 
amplifies the intensity for solid dense bone voxels, and this method could potentially give a more 
accurate result. This has, however, not been part of this study.  
Studying Figure 7, the mean difference in absorbed dose between CT, CBCT and sCT plans is 
small. The maximum difference is less than 1% which can be considered negligible compared to 
the desired and achievable levels of overall dose accuracy. Published data has suggested an 
acceptable level of overall dose accuracy to be between 3.5% and 5% [29]. All the invested 
treatment plans generated dose distributions with differences in mean dose well within the clinical 
tolerance. This concludes that recalculating treatment plans on the CBCT image and comparing the 
dose distribution to the calculation carried out on the sCT image can detect gross errors in the sCT 
image, regardless of density table used. Hence, the CBCT image can be used to ensure quality 
accuracy of the sCT image.  
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Dose distributions on the CBCT image with HU-RED CBCT generally resulted in the largest mean 
dose differences for all the investigated DVH metrics. The choice of density table is the only thing 
separating the treatment plans done on the CBCT images. This indicates that the standard HU to 
density table provides a more accurate HU to RED transformation than the CBCT based HU to 
density curve. The HU-RED CBCT should provide a more accurate dose distribution since the FOV 
varies more within CBCT images than CT images. Why this is not the case may be that the method 
of developing the HU-RED CBCT is not optimal. The extraction of the solid dense bone HU may 
affect the outcome result. Although since the amount of solid dense bone that is present in the 
investigated anatomy are expected to be fairly small. Therefore, this is likely to have a small impact 
on the dose calculation. A suggestion of improvement would be to use of deformable image 
registration to extract bone values and avoid the use of histograms, which were insufficient in this 
aspect. 
The structure set from the sCT images was copied and transferred onto the CT and CBCT images. 
All the datasets structures will then have the same volume size and position enabling the same 
treatment plan to be used. This contributes to a more impartial dose comparison. Although copying 
the structure set may contribute to mismatches with the CT and/or CBCT images. The delineated 
organs on the MRI images should not differ from the CT and/or CBCT images but due to variety in 
patient set up and/or dissimilar intestinal filling between the image sessions, this could be the case. 
If this is the case, the comparison of the mean dose difference may be affected. Deformable image 
registration could have been used to eliminate this affect. But the use of deformable image 
registration in a clinical setup may not be preferable.  
This study showed that verification of the sCT image can be done via dose distribution comparison 
between calculations carried out with sCT and CBCT images as basis. Recalculating the plan on 
the CBCT image resulted in a difference of mean dose to the PTV of 0.0% (HU-RED CT) and -
0.8% (HU-RED CBCT) when comparing calculations based on sCT and CBCT images. These 
uncertainties appear to be negligible compared to the overall dose accuracy.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
29 
 
6. Conclusion  
Phantom measurements showed that the kV CBCT systems at the clinic were stable in HU over 
time and relative to each other. The variation in HUs between one CBCT system and one CT system 
was considered to not have clinical impact. Differences between patient specific absorbed dose 
calculations based on sCT and CBCT images were small and considered to be within clinical 
tolerance. This indicates that dose plan recalculating on CBCT images for sCT images verification 
can be used in an MRI only workflow.  
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7. Future perspective 
In this study, the method of creating the HU-RED CBCT table was not optimal. The value for solid 
dense bone was obtained by using a phantom based measurement instead of patient based. Further 
work investigating other methods to estimate HUs based on patients would be interesting. Methods 
to filter out solid dense bone HU values in the CBCT image was tested as part of this project, but 
without success. Development of the filter method could be done or another approach could be 
tested. Applying threshold on the CBCT images may result in a patient based solid dense bone HU 
value.  
 
The aim in verifying the sCT image is mainly to detect catastrophic errors. The work done in this 
thesis contained comparisons with successfully generated sCT data sets. It would be of interest to 
investigate if the method could detect catastrophic errors in the sCT image. This is something that 
may be necessary to evaluate before actually using the CBCT image to verify the sCT image in a 
clinical workflow.    
 
Some patients lose weight during their treatment, changing their body contour and therefore 
altering the dose distribution. For these cases, it is of interest to evaluate whether the absorbed dose 
still fulfills the constrains for the PTV and OARs. One approach to investigate this is to recalculate 
the absorbed dose on a CBCT image. Treatment planning on Varian TrueBeam CBCT images 
showed that this could be done with the standard HU-RED CT table since it creates accurate dose 
distributions.  
 
This thesis focused on patient with prostate glandular cancer. It would be of interest to investigate 
whether the method of verifying the sCT image could be applied in other regions.   
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Appendix 1 
RapidArc treatment planning. The DVH comparison between CT/sCT, CBCTHU-RED CT/sCT and 
CBCTHU-RED CBCT/sCT for each patient is shown in the table.  
 Patient 1  Patient 2  
CT CBCTHU-
RED CT   
CBCTHU-
RED CBCT 
CT CBCTHU-
RED CT   
CBCTHU-
RED CBCT 
Body  
Max 
0.1 
 
1.0 
 
-0.1 
 
-0.4 0.2 -0,5 
 
PTV  
Mean  
-0.4 
 
-0.2 -1.1 
 
-0.4 
 
-0.3 
 
-1,1 
 
PTV  
V95% 
-0.1 
 
-0.1 
 
-0.4 
 
-0.0 -0.0 
 
-0,1 
 
PTV 
D99% 
-0.5 
 
-0.5 
 
-1.2 
 
-0.3 
 
-0.2 
 
-1,1 
 
CTV 
Mean 
-0.4 
 
-0.3 
 
-1.2 
 
-0.4 
 
-0.3 
 
-1,2 
 
CTV 
Min 
-0.4 
 
-0.2 
 
-1.1 
 
-0.5 
 
-0.4 
 
-1,2 
 
Bladder  
Mean 
0.1 
 
0.0 
 
-0.2 
 
-0.0 
 
-0.0 
 
-0,3 
 
Rectum  
Mean  
-0.1 
 
-0.0 -0.3 
 
-0.0 
 
0.0 
 
-0,2 
 
Rectum  
V90% 
-0.1 
 
-0.1 
 
-0.5 
 
-0.2 
 
-0.1 
 
-0,4 
 
Rectum  
V75% 
-0.1 
 
-0.1 
 
-0.3 
 
-0.1 
 
-0.1 
 
-0,2 
 
Rectum  
V65% 
-0.1 
 
-0.1 
 
-0.3 
 
-0.0 0.0 
 
-0,1 
 
Femoral Heads 
Max 
-0.1 
 
-0.2 
 
-0.3 
 
-0.2 
 
-0.5 
 
-0,7 
 
Femoral Heads 
Mean 
-0.0 
 
-0.2 -0.2 
 
-0.1 
 
-0.2 
 
-0,3 
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Appendix 1 – continue  
 Patient 3  Patient 4  
CT CBCTHU-
RED CT   
CBCTHU-
RED CBCT 
CT CBCTHU-
RED CT   
CBCTHU-
RED CBCT 
Body  
Max 
0.3 
 
1.4 0.2 
 
0.7 
 
0.7 
 
-0.0 
 
PTV  
Mean  
0.2 
 
0.4 
 
-0.5 
 
0.3 
 
0.2 
 
-0.6 
 
PTV  
V95% 
0.0 
 
0.0 
 
0.0 
 
0.1 
 
0.0 
 
-0.4 
 
PTV 
D99% 
-0.3 
 
0.4 
 
-0.6 
 
0.4 
 
0.1 
 
-0.5 
CTV 
Mean 
0.3 
 
0.4 
 
-0.5 
 
0.3 
 
0.2 
 
-0.6 
 
CTV 
Min 
0.2 
 
0.4 
 
-0.7 
 
0.1 
 
-0.1 
 
-0.9 
 
Bladder  
Mean 
0.1 
 
0.0 
 
-0.3 
 
0.2 
 
0.3 
 
-0.1 
 
Rectum  
Mean  
0.1 
 
N/A N/A 0.1 
 
0.3 
 
-0.1 
 
Rectum  
V90% 
-0.2 
 
N/A N/A -0.2 
 
-0.5 
 
-0.9 
 
Rectum  
V75% 
0.0 
 
N/A N/A -0.2 
 
-0.3 
 
-0.6 
 
Rectum  
V65% 
0.3 
 
N/A N/A -0.0 
 
-0.3 
 
-0.8 
 
Femoral Heads 
Max 
0.2 
 
0.1 
 
-0.1 
 
0.3 
 
0.0 
 
-0.2 
Femoral Heads 
Mean 
0.0 
 
-0.1 
 
-0.2 
 
0.1 
 
-0.0 
 
-0.2 
 
 
